(Q84788582)

English

Where are the new drugs to treat heart failure? Introduction to the special issue on "key signaling molecules in hypertrophy and heart failure"

scientific article published on 12 August 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

Where are the new drugs to treat heart failure? Introduction to the special issue on "key signaling molecules in hypertrophy and heart failure" (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

based on heuristic

inferred from title

author name string

Paul C Simpson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

12 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

435-437

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Novel targets for the treatment of heart failure: perspectives from a heart failure clinician and trialist

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Current NHLBI perspectives on translational heart failure research

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Heart failure drug discovery: scarred or ready for remodeling?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Preclinical studies of human disease: time to take methodological quality seriously.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Myocardial salvage in acute myocardial infarction--challenges in clinical translation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Cardiac myosin activation part 1: from concept to clinic

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Translational potential of thyroid hormone and its analogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Neuregulin-1β for the treatment of systolic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

The p38 mitogen-activated protein kinase pathway--a potential target for intervention in infarction, hypertrophy, and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Protein kinase Cα as a heart failure therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Myocardial protection at a crossroads: the need for translation into clinical therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Reengineering translational science: the time is right

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Can animal models of disease reliably inform human studies?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

You know what we need?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Transforming growth factor (TGF)-β signaling in cardiac remodeling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

β₂ AR agonists in treatment of chronic heart failure: long path to translation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

β-Arrestin: A signaling molecule and potential therapeutic target for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

CaMKII in myocardial hypertrophy and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Targeting GSK-3 family members in the heart: a very sharp double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Targeting AMPK for cardiac protection: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Isoform-selective HDAC inhibitors: Closing in on translational medicine for the heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Taking the heart failure battle inside the cell: small molecule targeting of Gβγ subunits

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Application of recombinant thioredoxin1 for treatment of heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Autophagy as a therapeutic target in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Nix Nought Nothing: Fairy tale or real deal

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Small heat shock protein 20 (HspB6) in cardiac hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Therapeutic targeting of innate immunity in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

The PGC-1 cascade as a therapeutic target for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2011.08.005

7 January 2021

Identifiers

10.1016/J.YJMCC.2011.08.005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21851824%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84788582&oldid=1985378271"